Alkem Laboratories · NSE: ALKEM · BSE: 539523
Q3 FY24 results · Oct–Dec 2023
Alkem Laboratories reported revenue from operations of ₹3,323.87 crore (up 9.3% from Q3 FY23) and net profit of ₹604.28 crore (up 31.4% from Q3 FY23) for Q3 FY24 (Oct–Dec 2023), on a consolidated basis.
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 3,323.87 | 3,040.91 | +9.3% | 3,440.17 | −3.4% |
| Other income | 93.64 | 45.33 | +106.6% | 63.19 | +48.2% |
| Total income | 3,417.51 | 3,086.24 | +10.7% | 3,503.36 | −2.5% |
| Profit before tax | 654.90 | 538.89 | +21.5% | 648.04 | +1.1% |
| Net profit for the period | 604.28 | 459.96 | +31.4% | 614.89 | −1.7% |
| Attributable to shareholders of the company | 594.96 | 454.71 | +30.8% | 620.52 | −4.1% |
| EPS, basic (₹) | 49.76 | 38.03 | +30.8% | 51.90 | −4.1% |
| Net margin (%) | 18.2 | 15.1 | 17.9 |
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,494.59 | 2,296.72 | +8.6% | 2,634.59 | −5.3% |
| Other income | 95.66 | 60.74 | +57.5% | 61.84 | +54.7% |
| Total income | 2,590.25 | 2,357.46 | +9.9% | 2,696.43 | −3.9% |
| Profit before tax | 534.38 | 435.95 | +22.6% | 638.72 | −16.3% |
| Net profit for the period | 504.23 | 388.89 | +29.7% | 646.51 | −22.0% |
| EPS, basic (₹) | 42.17 | 32.52 | +29.7% | 54.07 | −22.0% |
| Net margin (%) | 20.2 | 16.9 | 24.5 |
Consolidated
- Filed with BSE
- 10 Feb 2024, 12:13 IST
- Board meeting
- 09 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 10 Feb 2024, 12:13 IST
- Board meeting
- 09 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE